Hepatitis Monthly

Published by: Kowsar

Analytical Assessment of Interleukin - 23 and -27 Cytokines in Healthy People and Patients With Hepatitis C Virus Infection (Genotypes 1 and 3a)

Asghar Ashrafi Hafez 1 , Abbas Ahmadi Vasmehjani 2 , Rasoul Baharlou 2 , Seyed Dawood Mousavi Nasab 3 , Mohammad Hasan Davami 2 , * , Ahmad Najafi 2 , Negar Joharinia 2 , Hasan Rezanezhad 2 , Nayeb Ali Ahmadi 4 and Masoumeh Imanzad 5 , 6
Authors Information
1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology and Immunology, Jahrom University of Medical Sciences, Jahrom, IR Iran
3 Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
4 Department of Medical Lab Technology and Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Department of Social Medicine, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, IR Iran
6 Young Researchers Club, Shahr-e-Qods branch, Islamic Azad University, Tehran, IR Iran
Article information
  • Hepatitis Monthly: September 2014, 14 (9); e21000
  • Published Online: September 27, 2014
  • Article Type: Research Article
  • Received: June 7, 2014
  • Revised: July 20, 2014
  • Accepted: August 6, 2014
  • DOI: 10.5812/hepatmon.21000

To Cite: Ashrafi Hafez A, Ahmadi Vasmehjani A, Baharlou R, Mousavi Nasab S D, Davami M H, et al. Analytical Assessment of Interleukin - 23 and -27 Cytokines in Healthy People and Patients With Hepatitis C Virus Infection (Genotypes 1 and 3a), Hepat Mon. 2014 ;14(9):e21000. doi: 10.5812/hepatmon.21000.

Abstract
Copyright: Copyright © 2014, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345(1): 41-52[DOI][PubMed]
  • 2. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest. 2009; 119(7): 1745-54[DOI][PubMed]
  • 3. Ksiaa Cheikhrouhou L, Sfar I, Aounallah-Skhiri H, Aouadi H, Jendoubi-Ayed S, Ben Abdallah T, et al. Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection. Hepatobiliary Pancreat Dis Int. 2011; 10(3): 280-8[PubMed]
  • 4. Fainboim L, Chernavsky A, Paladino N, Flores AC, Arruvito L. Cytokines and chronic liver disease. Cytokine Growth Factor Rev. 2007; 18(1-2): 143-57[DOI][PubMed]
  • 5. Dharancy S, Conti F, Desreumaux P, Paris JC, Calmus Y. [Cytokine imbalance during hepatitis C virus infection. Consequences in hepatic pathophysiology]. Gastroenterol Clin Biol. 2001; 25(6-7): 595-604[PubMed]
  • 6. Jia HY, Du J, Zhu SH, Ma YJ, Chen HY, Yang BS, et al. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int. 2002; 1(3): 378-82[PubMed]
  • 7. Ryan EJ, O’Farrelly C. The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence. J Viral Hepat. 2011; 18(9): 601-7[DOI]
  • 8. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol. 2005; 5(7): 521-31[DOI][PubMed]
  • 9. Xu M, Mizoguchi I, Morishima N, Chiba Y, Mizuguchi J, Yoshimoto T. Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin Dev Immunol. 2010; 2010[DOI][PubMed]
  • 10. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science. 2003; 302(5645): 659-62[DOI][PubMed]
  • 11. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003; 278(3): 1910-4[DOI][PubMed]
  • 12. Hassoba H, Leheta O, Sayed A, Fahmy H, Fathy A, Abbas F, et al. IL-10 and IL-12p40 in Egyptian patients with HCV-related chronic liver disease. Egypt J Immunol. 2003; 10(1): 1-8[PubMed]
  • 13. Yoshimoto T, Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol. 2007; 179(7): 4415-23[PubMed]
  • 14. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol. 2006; 7(9): 929-36[DOI][PubMed]
  • 15. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol. 2007; 8(12): 1372-9[DOI][PubMed]
  • 16. Greenwell-Wild T, Vazquez N, Jin W, Rangel Z, Munson PJ, Wahl SM. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood. 2009; 114(9): 1864-74[DOI][PubMed]
  • 17. Frank AC, Zhang X, Katsounas A, Bharucha JP, Kottilil S, Imamichi T. Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus. J Interferon Cytokine Res. 2010; 30(6): 427-31[DOI][PubMed]
  • 18. Zhu C, Zhang R, Liu L, Rasool ST, Mu Y, Sun W, et al. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin Immunol. 2009; 131(1): 92-7[DOI][PubMed]
  • 19. Schvoerer E, Navas MC, Thumann C, Fuchs A, Meyer N, Habersetzer F, et al. Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy. J Med Virol. 2003; 70(4): 588-93[DOI][PubMed]
  • 20. El-Kady IM, Lotfy M, Badra G, El-Masry S, Waked I. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections. Scand J Immunol. 2005; 61(1): 87-91[DOI][PubMed]
  • 21. Zhang L, Miao L, Han F, Dou XG. [Cytokine levels in serum of patients with chronic hepatitis C and its significance]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011; 27(3): 301-3[PubMed]
  • 22. Mona F, Schaalan WAM, Hesham H, Amin VD. Correlation to interleukin-17, interleukin-23 and PⅢNP in hepatitis C virus genotype 4. World J Gastroen. 2012; 18(28): 3738-44
  • 23. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol. 2003; 170(10): 4886-90[PubMed]
  • 24. Ruckerl D, Hessmann M, Yoshimoto T, Ehlers S, Holscher C. Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1. Immunobiology. 2006; 211(6-8): 427-36[DOI][PubMed]
  • 25. Lee CH, Choi YH, Yang SH, Lee CW, Ha SJ, Sung YC. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology. 2001; 279(1): 271-9[DOI][PubMed]
  • 26. Waggoner SN, Hall CH, Hahn YS. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol. 2007; 82(6): 1407-19[DOI][PubMed]
  • 27. Tornero C, Alberola J, Tamarit A, Navarro D. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals. Clin Microbiol Infect. 2006; 12(6): 555-60[DOI][PubMed]
  • 28. Guzzo C, Hopman WM, Che Mat NF, Wobeser W, Gee K. Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27. AIDS. 2010; 24(9): 1371-4[DOI][PubMed]
  • 29. Murakami S, Okubo K, Tsuji Y, Sakata H, Takahashi T, Kikuchi M, et al. Changes in liver enzymes after surgery in anti-hepatitis C virus-positive patients. World J Surg. 2004; 28(7): 671-4[DOI][PubMed]
  • 30. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002; 123(4): 1367-84[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader